Sino Biopharmaceutical Limited (SBMFF) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Wan Chai, 홍콩. 현재 CEO는 S. Y. Tse.
SBMFF 을(를) 보유 IPO 날짜 2010-02-22, 24,379 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $13.58B.
Sino Biopharmaceutical Limited is a Hong Kong-incorporated research and development pharmaceutical conglomerate operating in China since 2000. The company develops and commercializes a diverse portfolio of pharmaceuticals across multiple therapeutic areas, including oncology, cardio-cerebral vascular, hepatitis, orthopedic, and respiratory medicines, as well as innovative chemical pharmaceuticals and parenteral nutritional products. Beyond pharmaceutical manufacturing, Sino Biopharmaceutical operates an integrated healthcare ecosystem comprising hospital operations, optometry services, health food production, pharmaceutical distribution, and medical technology consulting. The company organizes its operations through three main segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others, generating revenue from drug sales, healthcare services, and strategic investments.
